Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McColl

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
AIDS Care|February 1, 1996
Coping and social support as determinants of quality of life in HIV/AIDSJ Friedland, R Renwick, M McColl
Australian and New Zealand Journal of Public Health|April 1, 1996
Client follow-up at the Adelaide sexually transmitted disease clinicM McColl, G Hart, D Chung
Biochemical Society Transactions|May 1, 1994
Sidedness in cyanobacterial thylakoid membranesS M McColl, E H Evans
Chemosphere|July 11, 2008
Evaporative mass transfer behavior of a complex immiscible liquidColleen M McColl, Gwynn R Johnson, Mark L Brusseau
Sports Medicine (Auckland, N.Z.)|January 1, 1989
The effects of exercise on reproductive function in menD C Cumming, G D Wheeler, E M McColl
Biotechniques|February 12, 1998
Method to reduce the quantity of ethidium bromide required to stain DNA in agarose gelsM J Lucey, S M McColl, F C Manning
Bulletin of Environmental Contamination and Toxicology|July 11, 2002
Comparison of the toxicity of chromium III and chromium VI to cyanobacteriaS L Thompson, F C R Manning, S M McColl
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|April 1, 1990
The Canadian occupational performance measure: an outcome measure for occupational therapyM Law, S Baptiste, M McColl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2018
Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloonRobin Krol, Gill M McColl, Wim P M Hopman, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitroRima Kulkarni, Rebecca Hluhanich, Damian M McColl, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
AIDS Care|February 1, 1996
Coping and social support as determinants of quality of life in HIV/AIDSJ Friedland, R Renwick, M McColl
Australian and New Zealand Journal of Public Health|April 1, 1996
Client follow-up at the Adelaide sexually transmitted disease clinicM McColl, G Hart, D Chung
Biochemical Society Transactions|May 1, 1994
Sidedness in cyanobacterial thylakoid membranesS M McColl, E H Evans
Chemosphere|July 11, 2008
Evaporative mass transfer behavior of a complex immiscible liquidColleen M McColl, Gwynn R Johnson, Mark L Brusseau
Sports Medicine (Auckland, N.Z.)|January 1, 1989
The effects of exercise on reproductive function in menD C Cumming, G D Wheeler, E M McColl
Biotechniques|February 12, 1998
Method to reduce the quantity of ethidium bromide required to stain DNA in agarose gelsM J Lucey, S M McColl, F C Manning
Bulletin of Environmental Contamination and Toxicology|July 11, 2002
Comparison of the toxicity of chromium III and chromium VI to cyanobacteriaS L Thompson, F C R Manning, S M McColl
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|April 1, 1990
The Canadian occupational performance measure: an outcome measure for occupational therapyM Law, S Baptiste, M McColl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2018
Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloonRobin Krol, Gill M McColl, Wim P M Hopman, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitroRima Kulkarni, Rebecca Hluhanich, Damian M McColl, et al.
Pageof 4